Bookmarkers beware:
Bookmarks to pages other than the home page may not work after we change our server in April

BMJ No 7129 Volume 316 7 February 1998

This Week in BMJ | Editor's Choice | Press releases

Receive this page by email each week


Editorials

403 Do silicone breast implants cause connective tissue disease?
Cyrus Cooper, Elaine Dennison

404 Neonatal screening for cystic fibrosis
Nicholas J Wald, Joan K Morris

405 Missed problems and missed opportunities for addicted doctors
John Strang, Michael Wilks, Brian Wells, Jane Marshall

406 Turbulent future for school nursing and health visiting
Kate Billingham, David Hall

407 Caring for patients with chronic leg ulcer
C V Ruckley

409 Providing primary care in the accident and emergency department
I R S Robertson-Steel

410 Rationing health care
Albert Weale


News

411 Consultation on human cloning launched in UK
UK "drink drive" limit may be cut
More precise targeting of drugs in pipeline
Doctors' strike averted in Hungary
UK doctors' pay award phased again
Nurses' pay award will not help recruitment
Cardiac services to expand in Ireland
India approves leprosy vaccine
Bill Clinton's State of the Union address
France has more early deaths than Britain
Health secretary hits back at charges of bias
Professor Philip James profiled


Papers

417 Risk of connective tissue disease and related disorders among women with breast implants: a nationwide retrospective cohort study in Sweden
Olof Nyrén, Li Yin, Staffan Josefsson, Joseph K McLaughlin, William J Blot, Martin Engqvist, Lars Hakelius, John D Boice Jr, Hans-Olov Adami

422 Single dose vitamin A treatment in acute shigellosis in Bangladeshi children: randomised double blind controlled trial
Shahadat Hossain, Rabi Biswas, Iqbal Kabir, Shafique Sarker, Michael Dibley, George Fuchs, Dilip Mahalanabis

426 Mortality from overdose among injecting drug users recently released from prison: database linkage study
S R Seaman, R P Brettle, S M Gore

429 Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial
C Moynihan, J M Bliss, J Davidson, L Burchell, A Horwich

435 Evaluation of reagent strips in detecting asymptomatic bacteriuria in early pregnancy: prospective case series
Douglas G Tincello, David H Richmond

437 Is the emergency (999) service being misused? Retrospective analysis
Clifford Mann, Henry Guly

438 Raynaud's phenomenon after sympathetic denervation in patients with primary autonomic failure: questionnaire survey
Rajeev Mallipeddi, Christopher J Mathias

440 Drug points: Serious interaction between warfarin and oral terbinafine
J A Warwick, R J Corrall

Parotid swelling and terbinafine
J K Torrens, P H McWhinney

Nortriptyline intoxication induced by terbinafine
P-H M van der Kuy, P M Hooymans; A J B Verkaaik

435 Corrections: Randomised controlled trial to evaluate early discharge scheme for patients with stroke
Anthony G Rudd

441 Intranasal chlorhexidine resulting in anaphylactic circulatory arrest
Peter Moult


General practice

442 Qualitative study of educational interaction between general practitioners and specialists
Martin N Marshall


Clinical review

446 Science, medicine, and the future: Alzheimer's disease
Colin L Masters, Konrad Beyreuther

449 Grand Round: Mycobacterium paratuberculosiscervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease
John Hermon-Taylor, Nick Barnes, Chris Clarke, Caroline Finlayson

454 Lesson of the week: Pneumatic compression boots for prophylaxis against deep vein thrombosis: beware occult arterial disease
M J Oakley, E F Wheelwright, P J James

456 ABC of palliative care: Bereavement
Frances Sheldon


Education and debate

459 Ethical dilemma: Should doctors reconstruct the vaginal introitus of adolescent girls to mimic the virginal state?

Who wants the procedure and why
A Logmans, A Verhoeff, R Bol Raap, F Creighton, M van Lent

Commentary: The ethical issue is deceit
D D Raphael

Commentary: Promiscuity is acceptable only for men
Dinesh Bhugra

Commentary: Education about the hymen is needed
Sara Paterson-Brown

Commentary: Cultural complexities should not be ignored
Elspeth Webb

Commentary: Surgery is not what it seems
Lainie Friedman Ross

463 Lay perspectives: advantages for health research
Vikki A Entwistle, Mary J Renfrew, Steven Yearley, John Forrester, Tara Lamont

466 Continuing medical education: Learning and change: implications for continuing medical education
Robert D Fox, Nancy L Bennett


Letters

469 Bias in meta-analysis detected by a simple, graphical test
A E Stuck and others; J P Vandenbroucke; L Irwig and others; V Seagroatt and I Stratton; M Egger and others; P Langhorne; F Song and S Gilbody

471 British renal registry is fully electronic
D Ansell and others

472 Electronic record linkage to create diabetes registers
P J Leslie and others; S Treweek and others; D L Whitford and S H Roberts

473 Under half of senior house officers in Anglia in 1997 were United Kingdom graduates
J Biggs

473 UK encourages unrealistic expectations among overseas applicants for training
M K Sridhar

473 Adding methionine to every paracetamol tablet
S K Saha and R Kale; F N Leach and J M Braganza; N Chada; A E M McLean

474 British trial of transmyocardial revascularisation is continuing
N Caine and others

475 Comparison of assays for measuring plasma paracetamo
L Jones and others; R FitzPatrick and others

476 Prescription Medicines Code of Practice Authority investigates criticisms of advertisements
H Simmonds

476 Psychotropic drug treatment
A Lenox-Smith; T Harris and F Smith; C Paton and others

477 Media are too eager to link silicone to disease
N Collis and others


Obituaries

478 M Critchley, J M England, E C Gambrill, G St J Hallett, J M Hand, W Howel-Evans, J C Lindsay, R Lynn, A F McGlashan, J D Milne, A H W Nias, G H Pearce


Medicopolitical digest

480 Doctors who misuse alcohol
Management costs in England
Patients and research
Access to specialist register
GPs and merit awards
Rationing in general practice
Review body report 1998
Research assessment exercise
Section 36 payments
BMA council elections


Views & reviews

Soundings

482 None of our business?
Trisha Greenhalgh


Personal views

482 Living in two worlds
Ann Oakley

A psychiatrist in the family
Kamala-Maria Mueller


Medicine and the media

484 To screen or not to screen?
Kamran Abbasi


Medicine and books

485 Who's Afraid of Human Cloning? Gregory E Pence
Udo Schüklenk

Western Medicine: An Illustrated History Ed Irvine Loudon
Ann Dally


Minerva

486


S2 Career Focus Classified supplement

When your partner is your partner
Wayne Lewis


Editor's choice

What is happening with Alzheimer's disease?

All readers of the BMJare likely to be interested in what will happen with the management of Alzheimer's disease. A fifth of us may well develop it. Colin Masters and Konrad Beyreuther consider the disease in one of our continuing series entitled "Science, Medicine, and the Future" (p 446). The idea behind these articles is to describe what is happening now with the science of the disease and to speculate on what that may mean for clinicians in the future.

"An avalanche of knowledge" has confirmed that the generation of Aß amyloid from the amyloid precursor protein is the central pathway in the disease. How the Aß amyloid exerts its toxicity is unclear, but about half the genes that cause Alzheimer's disease have now been identified. The important environmental factors remain undiscovered. Low education, head trauma, smoking, concomitant vascular disease, diabetes, and the menopause all have effects - but they are modest and inconsequential. Might some subtle factor in the Western diet or lifestyle prove to be a major factor?

Masters and Beyreuther speculate that by 2008 we might see screening for the genes linked with the disease and possible presymptomatic treatment. There might also be drugs that will act on the amyloidogenic pathway and modify the course of the disease. Currently three drugs are on the market for treating Alzheimer's disease, four await approval, and 16 undergoing early clinical evaluation. Most act on the cholinergic system and are likely to have only a small effect, but drugs that target the amyloidogenic pathway are emerging.

Despite the high prevalence, immense cost, and exciting science of Alzheimer's disease many more column inches have probably been devoted by the media to the issue of whether silicone breast implants may cause connective tissue disease (p 403). No good epidemiological evidence has ever suggested that they do, and we publish today a Swedish study comparing connective tissue disease in 7,442 women with implants and 3,353 women who underwent breast reduction (p 417). There was no difference between the groups. Yet on the basis of weak anecdotal evidence American manufacturers have paid out over $4 billion to women with breast implants and the British government has set up an inquiry into the subject. A legal sideline is the probably baseless argument that women with silicone implants may damage their babies through breastfeeding (p 477).

Finally, a Paris newspaper attracted the attention of the BMJ100 years ago by proposing to "keep a doctor" in the way a London tailor kept a poet (p 448). The journal was snooty, and a century later we are still suspicious of doctors who peddle their wares in the newspapers (p 484).


Home | Current contents | Past issues | Classified ads | Career Focus | Feedback
Collections | About this site | About the BMJ | BMA | Medline